Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
80 hedge funds and large institutions have $100M invested in Genesis Healthcare, Inc. in 2015 Q1 according to their latest regulatory filings, with 80 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
41% less call options, than puts
Call options by funds: $181K | Put options by funds: $306K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$16.8M |
| 2 |
CC
Cannell Capital
Alta,
Wyoming
|
+$11.2M |
| 3 |
DM
Deerfield Management
New York
|
+$10.8M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$6M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.13M |
Top Sellers
GEN Hedge Fund Activity: Q1 2015 in Review
80 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q1 2015, worth a combined $100M.
Buyers outnumbered sellers: 80 funds opened new GEN positions and 0 closed out — a net gain of 80 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Invesco, opening a new position worth an estimated $16.8M.
- 80 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q1 2015, up from 0 in Q4 2014.
- Funds reported $100M of Genesis Healthcare, Inc. stock for Q1 2015.
- 80 funds opened new Genesis Healthcare, Inc. positions in Q1 2015 and 0 closed out, a net change of +80 holders.
- The largest Genesis Healthcare, Inc. buyer in Q1 2015 was Invesco, an estimated $16.8M added.
Based on aggregated 13F filings for Q1 2015.